Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt

Standard

Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease : A Double-Center Cohort Study. / Attauabi, Mohamed; Burisch, Johan; Seidelin, Jakob Benedict.

I: Inflammatory Bowel Diseases, Bind 27, Nr. 3, 2021, s. e37-e38.

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt

Harvard

Attauabi, M, Burisch, J & Seidelin, JB 2021, 'Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study', Inflammatory Bowel Diseases, bind 27, nr. 3, s. e37-e38. https://doi.org/10.1093/ibd/izaa297

APA

Attauabi, M., Burisch, J., & Seidelin, J. B. (2021). Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study. Inflammatory Bowel Diseases, 27(3), e37-e38. https://doi.org/10.1093/ibd/izaa297

Vancouver

Attauabi M, Burisch J, Seidelin JB. Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study. Inflammatory Bowel Diseases. 2021;27(3):e37-e38. https://doi.org/10.1093/ibd/izaa297

Author

Attauabi, Mohamed ; Burisch, Johan ; Seidelin, Jakob Benedict. / Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease : A Double-Center Cohort Study. I: Inflammatory Bowel Diseases. 2021 ; Bind 27, Nr. 3. s. e37-e38.

Bibtex

@article{0c5cb77b9fe64b34bc354c22b54f5c4d,
title = "Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study",
keywords = "perianal fistulizing Crohn disease, ustekinumab",
author = "Mohamed Attauabi and Johan Burisch and Seidelin, {Jakob Benedict}",
year = "2021",
doi = "10.1093/ibd/izaa297",
language = "English",
volume = "27",
pages = "e37--e38",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "Lippincott Williams & Wilkins",
number = "3",

}

RIS

TY - JOUR

T1 - Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease

T2 - A Double-Center Cohort Study

AU - Attauabi, Mohamed

AU - Burisch, Johan

AU - Seidelin, Jakob Benedict

PY - 2021

Y1 - 2021

KW - perianal fistulizing Crohn disease

KW - ustekinumab

U2 - 10.1093/ibd/izaa297

DO - 10.1093/ibd/izaa297

M3 - Comment/debate

C2 - 33200769

AN - SCOPUS:85097191469

VL - 27

SP - e37-e38

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

IS - 3

ER -

ID: 260306075